PRECISION MEDICINE IN CLINICAL TREATMENT FOR HEPATOCELLULAR CARCINOMA PATIENTS WITH BCLC STAGE C

被引：0
|
作者：
Lin, Chih Wen [1 ,2 ]
Lo, Gio-Ho [1 ]
Lee, Po-Huang [3 ]
Wu, Tsung-Chin [4 ]
Yeh, Jen-Hao [4 ]
Hsiao, Pojen [4 ]
Chen, Yaw-Sen [3 ]
机构：
[1] E Da Hosp, Med, Kaohsiung, Taiwan
[2] I Shou Univ, Kaohsiung, Taiwan
[3] E Da Hosp, Surg, Kaohsiung, Taiwan
[4] E Da Dachang Hosp, Med, Kaohsiung, Taiwan
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
368
引用
收藏
页码：234A / 234A
页数：1
相关论文
共 50 条
  • [1] Impact of BCLC treatment stage migration in the survival of patients with hepatocellular carcinoma
    Acosta-Lopez, S.
    Bethencourt, D. D.
    Plata-Bello, J.
    Garrido, E. B.
    Hernandez, F. A. P.
    Rodriguez, A. G.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S208 - S209
  • [2] Need for subclassification of BCLC-C stage hepatocellular carcinoma and treatment strategies
    Hong, Seung Dok
    Jun, Chung Hwan
    Choi, Sung Kyu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 424 - 424
  • [3] Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma
    Liu, Kai-Cai
    Hao, Ying-Hong
    Lv, Wei-Fu
    Jia, Wei-Dong
    Ji, Chu-Shu
    Zhou, Chun-Ze
    Cheng, De-Lei
    Xu, Shao-Bao
    Gao, Zong-Gen
    Su, Ming-Xue
    Shi, Chang-Sheng
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 3461 - 3468
  • [4] Response and Survival in Patients of BCLC Stage C Hepatocellular Carcinoma Receiving SBRT and Immunotherapy
    Zhou, J.
    Tang, Y.
    Duan, J.
    Sheng, L.
    Yang, Q.
    Wang, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E185 - E185
  • [5] The role of locoregional RT in BCLC stage C hepatocellular carcinoma patients treated with sorafenib
    Chang, W. I.
    Kim, B. H.
    Chie, E. K.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S756 - S756
  • [6] Hepatectomy for hepatocellular carcinoma in stage B and C of BCLC classification: A feasible, safe, and effective treatment
    Torzilli, G.
    Donadon, M.
    Marconi, M.
    Del Fabbro, D.
    Palinisano, A.
    Spinelli, A.
    Bianchi, P.
    Montorsi, M.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) : 5 - 5
  • [7] TACE combined with apatinib for the treatment of BCLC stage C of hepatocellular carcinoma: A restrospective controlled study
    Kan, Xuefeng
    Xiong, Bin
    Wang, Yong
    Liang, Bin
    Zhou, Guofeng
    Zheng, Chuansheng
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [8] The Efficacy and Prognostic Factors of the Combination of TACE and Apatinib for the Treatment of BCLC Stage C Hepatocellular Carcinoma
    Liu, Shun
    Liu, Kai-Cai
    Lv, Wei-Fu
    Lu, Dong
    Zhu, Xian-Hai
    Jiang, Bo
    Tan, Yu-Lin
    Wang, Guo-Xiang
    FRONTIERS IN MEDICINE, 2021, 8
  • [9] Significant of Hepatectomy for Stage B and C Hepatocellular Carcinoma in the BCLC Classification
    Kamiyama, Toshiya
    Yokoo, Hideki
    Orimo, Tatsuya
    Wakayama, Kenji
    Shimoda, Shingo
    Einama, Takahiro
    Kamachi, Hirofumi
    Yamashita, Kenichiro
    Shimamura, Tsuyoshi
    Taketomi, Akinobu
    HEPATOLOGY, 2016, 64 : 689A - 689A
  • [10] Precision Medicine for Hepatocellular Carcinoma: Clinical Perspective
    Galun, Danijel
    Mijac, Dragana
    Filipovic, Aleksandar
    Bogdanovic, Aleksandar
    Zivanovic, Marko
    Masulovic, Dragan
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (02):
12345